secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001437749-25-004124
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics announces 1-for-50 reverse stock split effective Feb 20, 2025
--------------------------------------------------------------------------------

- Reverse stock split approved by stockholders on Feb 3, 2025; ratio set at 1-for-50.
- Effective at 5:00 p.m. ET on Feb 20, 2025; adjusted trading begins Feb 21 under ticker WINT.
- Aimed at meeting Nasdaq $1.00 minimum bid price requirement; new CUSIP: 97382D600.
- Post-split outstanding shares reduced to approximately 700,000; no fractional shares issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774925004124/0001437749-25-004124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774925004124/wint20250217_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-004124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer